32 years Patient came with a headache, unable to remember subjects which

Question

Accepted Answer

Likely diagnostic formulation The presentation is most consistent with problematic or compulsive sexual behaviour only if there is persistent impaired control, marked distress or functional impairment, and continuation despite adverse consequences; frequency of masturbation alone (6–7 times weekly) does not establish a disorder. This distinction is a clinical inference because the provided sources identify compulsive sexual behaviour/hypersexuality as an impulse-control manifestation but do not provide diagnostic criteria. ^2,^3,^4,^5 Assess depression and anxiety as potential drivers or consequences of the sexual behaviour, including symptom severity, temporal relationship to masturbation/sexual activity, psychosocial stressors, relationship factors, sexual trauma, and effect on functioning. ^1 Assess for a mood elevation syndrome or other impulse-control disorder, including reduced need for sleep, elevated or irritable mood, increased goal-directed activity, spending, gambling, binge eating, substance use, and other risky behaviour; this is clinically important because hypersexuality can occur within impulse-control disorders. ^2,^3,^4,^5 Take a full medication and recreational-drug history, specifically asking about dopamine agonists such as pramipexole, which are associated with compulsive sexual behaviour/hypersexuality and other impulse-control manifestations. ^2,^3,^4,^5 Immediate ejaculation after penetration should be characterised separately as an ejaculation concern, including onset, context, distress, control, erectile quality, libido, arousal, orgasm, and relationship impact. The supplied NICE material recommends assessment of sexual desire, arousal, ejaculation, orgasm, relationship context, mental health, and functional impact when assessing male sexual difficulties. ^1 Headache, new short-term memory difficulty, fatigue, and mood change require a neurological and systemic differential rather than attribution to masturbation alone; examine for focal neurological signs, visual symptoms, seizures, altered consciousness, endocrine symptoms, and other red flags, with urgent same-day assessment or emergency referral if acute neurological deficit, seizure, confusion, papilloedema/visual disturbance, or a sudden severe headache is present. This triage recommendation is clinical practice inference and is not specified in the supplied excerpts. Primary-care assessment Document onset, duration, triggers, compulsive features, loss of control, time spent, pornography use, failed attempts to reduce behaviour, consequences, safeguarding issues, sexual risk-taking, and whether guilt reflects distress, cultural or religious beliefs, or actual harmful consequences. The NICE sexual-health assessment framework includes sexual aversion or pain, cultural or religious beliefs, relationship issues, anxiety, depression, previous sexual trauma or abuse, and effects on emotional wellbeing, relationships, and daily functioning. ^1 Undertake structured mental-health assessment, including suicidality/self-harm risk, depressive symptoms, anxiety symptoms, sleep, alcohol and drugs, and screening for manic/hypomanic symptoms. Depression and anxiety are recognised psychogenic contributors to male sexual symptoms. ^1 Review medical history for diabetes, cardiovascular disease, hypertension, kidney or liver disease, endocrine disease, neurological disease, prior pelvic/urological surgery, and prescribed, over-the-counter, online, hormonal, anabolic, and recreational substances. Organic and drug-related causes of male sexual symptoms include diabetes, hypogonadism, hyperprolactinaemia, neurological/CNS disease, chronic kidney or liver disease, antidepressants, and recreational drugs. ^1 Perform focused examination including blood pressure, heart rate, waist/cardiometabolic assessment, signs of testosterone deficiency, external genital examination, and targeted neurological examination; include fundoscopy where headache or visual symptoms raise concern for raised intracranial pressure. NICE advises examination for cardiovascular risk factors, testosterone deficiency, and genital/prostatic pathology according to clinical judgement. ^1 Investigations to exclude organic pathology Check HbA1c, lipid profile, and a fasting morning total testosterone level, as NICE recommends these tests in all men assessed for erectile dysfunction; in this case they may help identify diabetes, cardiometabolic risk, or hypogonadism contributing to fatigue, libido or sexual symptoms. ^1 Use additional blood tests selectively according to history and examination; for this presentation, reasonable targeted tests include full blood count, urea/electrolytes, liver function tests, thyroid function, vitamin B12/folate, ferritin, prolactin, and repeat/confirmatory gonadal testing with LH/FSH if testosterone is low. NICE specifies that further blood testing should be determined by the likely underlying cause and clinical judgement, while identifying hypogonadism and hyperprolactinaemia as endocrine causes of male sexual dysfunction. ^1 Consider HIV and STI testing where sexual history indicates exposure risk, and urine testing where urinary symptoms or diabetes are suspected; this is clinical practice inference rather than a specific recommendation in the supplied excerpts. Arrange urgent neurological assessment and consider neuroimaging when headache plus cognitive change is progressive, unexplained, associated with abnormal neurological examination, visual-field/endocrine features, seizures, or other intracranial red flags; this is clinical practice inference rather than a specific recommendation in the supplied excerpts. Management in primary care Provide non-judgemental psychoeducation that masturbation frequency is not itself pathological, and agree patient-centred goals focused on reducing loss of control, distress, risk, and interference with work, relationships, sleep, or mental health. This is clinical practice inference; the supplied sources support assessment of psychosocial impact rather than a numerical threshold. ^1 Offer or refer for structured psychological therapy addressing compulsive sexual behaviour, guilt/shame, mood symptoms, anxiety, triggers, avoidance, and relapse prevention; psychosexual or relationship counselling and mental-health referral are appropriate where psychogenic, relationship, or complex/severe mental-health factors are present. ^1 Address lifestyle and contributing factors, including sleep, activity, alcohol reduction, smoking cessation, weight management where relevant, and optimisation of medical comorbidities. NICE recommends lifestyle/risk-factor modification and optimisation of underlying conditions for male sexual dysfunction. ^1 If a dopamine agonist is implicated, discuss promptly with the initiating specialist before dose reduction or discontinuation, because compulsive sexual behaviour is a recognised adverse effect and withdrawal/tapering can cause anxiety, depression, fatigue, sweating, pain, and apathy. ^2,^3,^4,^5 For clinically significant depression or anxiety, use standard NICE-concordant stepped care with psychological therapy as appropriate and an SSRI as a usual first-line antidepressant when medication is indicated; choice should consider baseline sexual symptoms because SSRIs can contribute to erectile dysfunction and other sexual adverse effects. The supplied material identifies SSRIs and several other antidepressants as potential drug contributors to erectile dysfunction. ^1 No first-line medicine for compulsive sexual behaviour is established by the supplied guideline excerpts; treat identified depression, anxiety, substance use, medication effects, endocrine disease, or neurological disease, and seek specialist mental-health/psychosexual input for persistent impairment or risk. ^1,^2,^3,^4,^5 PDE-5 inhibitors are relevant only if he also has erectile dysfunction, defined as persistent inability to attain and maintain an erection sufficient for satisfactory sexual performance; they do not treat compulsive sexual behaviour or immediate ejaculation. NICE advises PDE-5 inhibitor treatment for erectile dysfunction when clinically appropriate, with follow-up at 6–8 weeks. ^1 Hair loss or baldness There is no evidence in the provided sources that frequent masturbation causes hair loss or baldness. ^1,^2,^3,^4,^5 Assess hair loss independently for common dermatological, endocrine, nutritional, medication-related, or stress-related causes if it is present; this is clinical practice inference rather than a recommendation in the supplied excerpts.

32 years Patient came with a headache, unable to remember subjects which

Key References

Related Knowledge Topics

Related clinical resources